Trial intelligence / Profile preview

Dose-comparison trial of remimazolam tosylate for general anesthesia in short general surgery

ChiCTR2000038094Phase 4Not yet recruiting

Sponsor
Suining Central Hospital
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of remimazolam and propofol in general anesthesia (4 arms), sponsored by Suining Central Hospital. Primary endpoints: Consciousness vanishing time and Withdrawal time. Planned start Aug 2020; status: not yet recruiting.

02

Drugs

remimazolampropofol
03

Conditions

general anesthesia

Beyond the preview

Go deeper on ChiCTR2000038094.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000038094.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call